JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB188288

Cy5® Conjugation Kit (Fast) - Lightning-Link®

5

(1 Review)

|

(27 Publications)

Cy5® Conjugation Kit (Fast) - Lightning-Link® (ab188288) offers several standout features:

- Rapid Conjugation: achieve Cy5® labeling in under 20 minutes with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies, proteins, and peptides. Cy5® labeled antibodies can be used immediately in applications such as Western blot (WB), ELISA, and Immunohistochemistry (IHC) without further purification.
- Confidence: cited in over 20 publications.
7 Images
Immunocytochemistry - Cy5® Conjugation Kit (Fast) - Lightning-Link® (AB188288)
  • ICC

PubMed

Lee, Yoon Seon, et al used Cy5® Conjugation Kit (Fast) - Lightning-Link® (ab188288) as part of examining the translocation and localization of newly developed peptide derived from CPNE7 (Cpne7-DP) . They used the kit to conjugate Cy5® to Cpne7-DP oligopeptide for use in immunocytochemistry.
The intracellular distribution of Cpne7-DP is shown after odontoblastic MDPC-23 cells were treated with Cy5-labeled Cpne7-DP (10 μg/mL).

Image from Lee et al., Materials, 13(20):4618; doi: 10.3390/ma13204618. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Schematic Diagram - Cy5® Conjugation Kit (Fast) - Lightning-Link® (AB188288)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how the Lightning-Link®(Fast) labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for just 15 minutes. Please see the ab188288 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Fluorescence Microscopy - Cy5® Conjugation Kit (Fast) - Lightning-Link® (AB188288)
  • Fluorescence Microscopy

PubMed

Li, Tiankuan, et al used Cy5® Conjugation Kit (Fast) - Lightning-Link® (ab188288) as part of examining immunotherapeutical treatments for lung cancer. They used the kit to conjugate Cy5® to anti-PD-L1 mAb for use in fluorescence microscopy.
CLSM images of docetaxel and CY5-labelled anti-PD-L1 mAb-co-loaded microbubbles with a shell containing FITC, scale bar = 20 μm.

Image from Li, Tiankuan, et al., Biomaterials science, 8(5):1418-1430. doi: 10.1039/c9bm01575b. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/3.0/

Immunocytochemistry/ Immunofluorescence - Cy5® Conjugation Kit (Fast) - Lightning-Link® (AB188288)
  • ICC/IF

PubMed

Cy5® Conjugation Kit - Lightning-Link® labeling NK2A peptide for confocal microscopy.

Dassanayake, Rohana P et al used ab188288 as part of examining the antimicrobial activity of bovine NK-lysin-derived peptides.

They used the kit to conjugate Cy5® to NK2A peptide for use in confocal microscopy.

H. somni was incubated with unconjugated Cy5 (A) or 20 μM NK2A-Cy5 conjugate for 30 min and bacterial nuclear contents were stained with DAPI. NK2A-Cy5 conjugate is shown in red and DAPI is shown in blue.

Image from Dassanayake RP et al., PloS One, 12(8):e0183610. Fig 4.; doi:10.1371/journal.pone.0183610. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Flow Cytometry - Cy5® Conjugation Kit (Fast) - Lightning-Link® (AB188288)
  • Flow Cyt

PubMed

Lindenburg, Laurens, et al used Cy5® Conjugation Kit (Fast) - Lightning-Link® (ab188288) as part of examining microemulsion-based bead display screening of the ZIgE SpliMLiB library. They used the kit to conjugate Cy5® to Native human IgE protein (Azide free) (ab65866) for use in FACS.
(A) Schematic overview of a round of SpliMLiB-enabled directed evolution of ZIgE. SpliMLiB beads (i) were singly encapsulated in emulsion IVTT at 37°C for 1 h (ii), sufficient time to allow for both ZIgE-SpyCatcher variants' expression as well as for their SpyTag-SpyCatcher-mediated immobilisation on the bead surface, after which the emulsion was broken, and the washed beads were exposed to Cy5-labelled IgE (iii), followed by flow cytometric sorting of beads based on Cy5 signal (iv). (B) Representative histogram recorded during the flow cytometric sorting of SpliMLiB ZIgE library beads. The range of fluorescence intensity used for each of the sorting gates 1-4 is indicated. (C) Analysis of pooled, recovered and subcloned DNA from the sorting gates set out in panel B. DNA was used to express protein in IVTT under bulk, i.e. non-emulsion conditions, in the presence of SpyTag-functionalised microbeads. The microbeads, having captured the SpyCatcher fusion proteins, were then incubated with 200 nM IgE-Cy5 and analysed by flow cytometry. Cy5 fluorescence intensity was normalised to a sample prepared from beads exposed to purified ZIgEwild-type-SpyCatcher protein (WT, grey bar). Negative control (NC) was beads not exposed to any ZIgE-SpyCatcher protein. (D) Analysis of bacterially expressed & purified variants derived from the stringently sorted library output from FACS sorting gate 4. Beads that had been bound with ZIgE-SpyCatcher variants were incubated with 200 nM IgE-Cy5 and analysed by flow cytometry. ZIgEwild-type-SpyCatcher (labelled WT) was included as control and was used to normalise all fluorescent values. The variant showing the highest Cy5 median signal (variant 33, marked by a single asterisk) and second highest (variant 44, marked by a double asterisk) signal were taken forward for further analysis. (E) As panel D, except for 48 randomly picked clones derived from the unsorted SpliMLiB input library beads. (F) Frequencies of amino acids encountered in selected variants displaying a higher binding signal than ZIgEwild-type-SpyCatcher (17 in total). The most frequent amino acid at each position is indicated in bold to emphasise it.

Image from Lindenburg, Laurens, et al., Nucleic acids res., 8(11): e63; doi: 10.1093/nar/gkaa270. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Western blot - Cy5® Conjugation Kit (Fast) - Lightning-Link® (AB188288)
  • WB

PubMed

Mody, Karishma T., et al used Cy5® Conjugation Kit (Fast) - Lightning-Link® (ab188288) as part of examining the integrity of Bm86 protein postlabeling. They used the kit to conjugate Cy5® to R. micr-protein ladder, lane 5-Cy5-Bm86 protein, lane 7-Cy5-Bm86/ Rho-SV-140-C18 Supernatant, lane 8-Cy5-Bm86/Rho-SV-140-C18 pellet (first antibody 869 polyclonal sheep 1/5,000; second antibody monoclonal anti-goat/sheep 1/10,000). The Cy5-labeled Bm86 retained its native antigenicity as it was recognized by the antibodies in serum from a sheep immunized with the unlabeled antigen from a previous study.

false

Image from Mody et al., Front bioeng biotechnol., 8:606652; doi: 10.3389/fbioe.2020.606652. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

FRET - Cy5® Conjugation Kit (Fast) - Lightning-Link® (AB188288)
  • FRET

PubMed

Mellal, Katia, et al used Cy5® Conjugation Kit (Fast) - Lightning-Link® (ab188288) as part of examining effects of MPE-001 on the CD36/TLR2 interaction. They used the kit to conjugate Cy5® to anti-CD36 antibody (ab80080) for use in FRET.
Peritoneal MPs were stimulated with 300 ng/ml R-FSL1 in the presence of 10-7 M MPE-001 or vehicle. (A) MPE-001 disrupted the interaction between CD36 labeled with Cy5 (red) using the Cy5® Conjugation Kit (Fast) - Lightning-Link® (ab188288) and TLR2 labeled with Cy3 (green) using the Cy3® Conjugation Kit (Fast) - Lightning-Link® (ab188287) as assessed by FRET after 5 min stimulation with R-FSL1. (B) Percentage of energy transfer measured using LSM-700 confocal microscope (Zeiss). One-way ANOVA test with Newman-Keuls post-test for multiple comparison was performed. *P<0.05, **P<0.01 and ***P <0.001 vs R-FSL1. Data are shown as mean ±S.E.M.

Image from Mellal et al., Sci rep., 9(1):12903. doi: 10.1038/s41598-019-49472-8. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Key facts

Product details

Cy5® Conjugation Kit (Fast) - Lightning-Link® (ab188288) uses a simple and quick process for labeling / conjugation of antibodies. It can also be used to conjugate other proteins or peptides.

To conjugate an antibody to Cy5® using this kit:
- add modifier to antibody and incubate for 15 min
- add quencher and incubate for 5 min

The Cy5® conjugated antibody can be used immediately in Flow cytometry, WB, ELISA, IHC etc. No further purification is required and 100% of the antibody is recovered for use.

Learn about our antibody labeling kits and their advantages here.

Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our antibody purification and concentration kits.
Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

Amount and volume of antibody for conjugation to Cy5

Kit size Recommended
amount of antibody1
Maximum
amount of antibody
Maximum antibody
volume2
3 x 10 µg 3 x 10 µg 3 x 20 µg 3 x 10 µL
100 µg 1 x 100 µg 1 x 200 µg 1 x 100 µL
3 x 100 µg 3 x 100 µg 3 x 200 µg 3 x 100 µL
1 mg 1 x 1 mg 1 x 2 mg 1 x 1 mL

1 Using the maximum amount of antibody may result in less labelling per antibody.

2 Ideal antibody concentration is 1mg/mL. 0.5 - 1 mg/mL can be used if the maximum antibody volume is not exceeded. Antibodies > 2 mg/mL or < 0.5 mg/mL should be diluted /concentrated.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50mM / 0.6% Tris1 0.1% BSA2 50% glycerol
0.1% sodium azide PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%
2 BSA can also interfere with the use of the conjugated antibody in tissue staining.

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® Rapid Cy5 Labeling Kit. 342-0005 is the same as the 100 µg size. 342-0010 is the same as the 3 x 100 µg size. 342-0030 is the same as the 3 x 10 µg size. 342-0015 is the same as the 1 mg size.

What's included?

{ "values": { "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab188288-3x10ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB188288-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB188288-CMP03" }, { "size":"3 x 10 µg", "name":"Cyanine Dye5", "number":"AB188288-CMP01" } ] }, "3x100g": { "sellingSize": "3 x 100 µg", "publicAssetCode":"ab188288-3x100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB188288-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB188288-CMP03" }, { "size":"3 x 100 µg", "name":"Cyanine Dye5", "number":"AB188288-CMP01" } ] }, "1mg": { "sellingSize": "1 mg", "publicAssetCode":"ab188288-1mg", "assetComponentDetails": [ { "size":"1 x 1 mg", "name":"Cyanine Dye5", "number":"AB188288-CMP01" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB188288-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB188288-CMP03" } ] }, "100g": { "sellingSize": "100 µg", "publicAssetCode":"ab188288-100ug", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Cyanine Dye5", "number":"AB188288-CMP01", "productcode":"" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB188288-CMP03", "productcode":"" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB188288-CMP02", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Ambient - Cannot Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Target data

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

Cell biology and toxicology 41:44 PubMed39937362

2025

Enhancing cardiac repair post-myocardial infarction: a study on GATM/Gel hydrogel therapeutics.

Applications

Unspecified application

Species

Unspecified reactive species

Te Li,Lijuan Ding,Qiang Wang,Jianing Ma,Shudong Wang

Molecular medicine (Cambridge, Mass.) 30:253 PubMed39707183

2024

CXCL4 deficiency limits M4 macrophage infiltration and attenuates hyperoxia-induced lung injury.

Applications

Unspecified application

Species

Unspecified reactive species

Bingrui Yu,Siyuan Jia,Yu Chen,Rong Guan,Shuyu Chen,Wanwen Tang,Tianping Bao,Zhaofang Tian

Cell metabolism 34:1280-1297.e9 PubMed36070681

2022

Methionine metabolism controls the B cell EBV epigenome and viral latency.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Guo,Jin Hua Liang,Yuchen Zhang,Michael Lutchenkov,Zhixuan Li,Yin Wang,Vicenta Trujillo-Alonso,Rishi Puri,Lisa Giulino-Roth,Benjamin E Gewurz

Nature communications 13:4308 PubMed35879297

2022

Pancreatic tumor eradication via selective Pin1 inhibition in cancer-associated fibroblasts and T lymphocytes engagement.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaye Liu,Yang Wang,Chunyang Mu,Meng Li,Kewei Li,Shan Li,Wenshuang Wu,Lingyao Du,Xiaoyun Zhang,Chuan Li,Wei Peng,Junyi Shen,Yang Liu,Dujiang Yang,Kaixiang Zhang,Qingyang Ning,Xiaoying Fu,Yu Zeng,Yinyun Ni,Zongguang Zhou,Yi Liu,Yiguo Hu,Xiaofeng Zheng,Tianfu Wen,Zhihui Li,Yong Liu

Nature communications 13:2540 PubMed35534484

2022

Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches.

Applications

Unspecified application

Species

Unspecified reactive species

Amos C Lee,Yongju Lee,Ahyoun Choi,Han-Byoel Lee,Kyoungseob Shin,Hyunho Lee,Ji Young Kim,Han Suk Ryu,Hoe Suk Kim,Seung Yeon Ryu,Sangeun Lee,Jong-Ho Cheun,Duck Kyun Yoo,Sumin Lee,Hansol Choi,Taehoon Ryu,Huiran Yeom,Namphil Kim,Jinsung Noh,Yonghee Lee,Inyoung Kim,Sangwook Bae,Jinhyun Kim,Wooseok Lee,Okju Kim,Yushin Jung,Changhoe Kim,Seo Woo Song,Yeongjae Choi,Junho Chung,Byung Gee Kim,Wonshik Han,Sunghoon Kwon

Frontiers in immunology 13:838966 PubMed35444660

2022

Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Liu,Yanli Liu,Zhen Zhao,Yuanke Li,Bahaa Mustafa,Zhijin Chen,Ashutosh Barve,Akshay Jain,Xiaolan Yao,Guangfu Li,Kun Cheng

Cell reports 38:110411 PubMed35263599

2022

Epstein-Barr virus BNRF1 destabilizes SMC5/6 cohesin complexes to evade its restriction of replication compartments.

Applications

Unspecified application

Species

Unspecified reactive species

Stephanie Pei Tung Yiu,Rui Guo,Cassie Zerbe,Michael P Weekes,Benjamin E Gewurz

Frontiers in immunology 12:713704 PubMed34447380

2021

IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Wissam Charab,Matthew G Rosenberger,Haridha Shivram,Justin M Mirazee,Moses Donkor,Soumya R Shekhar,Donjeta Gjuka,Kimberly H Khoo,Jin Eyun Kim,Vishwanath R Iyer,George Georgiou

Frontiers in bioengineering and biotechnology 8:606652 PubMed33537291

2021

Characterization of the Biodistribution of a Silica Vesicle Nanovaccine Carrying a Protective Antigen With Live Animal Imaging.

Applications

Unspecified application

Species

Unspecified reactive species

Karishma T Mody,Bing Zhang,Xun Li,Nicholas L Fletcher,Dewan T Akhter,Sandy Jarrett,Jun Zhang,Chengzhong Yu,Kristofer J Thurecht,Timothy J Mahony,Neena Mitter

Cell 184:1000-1016.e27 PubMed33508229

2021

Functional characterization of the dural sinuses as a neuroimmune interface.

Applications

Unspecified application

Species

Unspecified reactive species

Justin Rustenhoven,Antoine Drieu,Tornike Mamuladze,Kalil Alves de Lima,Taitea Dykstra,Morgan Wall,Zachary Papadopoulos,Mitsuhiro Kanamori,Andrea Francesca Salvador,Wendy Baker,Mackenzie Lemieux,Sandro Da Mesquita,Andrea Cugurra,James Fitzpatrick,Sanja Sviben,Ross Kossina,Peter Bayguinov,Reid R Townsend,Qiang Zhang,Petra Erdmann-Gilmore,Igor Smirnov,Maria-Beatriz Lopes,Jasmin Herz,Jonathan Kipnis
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com